{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:26:10Z","timestamp":1790861170249,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014960","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000}}],"reference-count":90,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014960.pub2","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:17:15Z","timestamp":1710404235000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antibiotics for treatment of leptospirosis"],"prefix":"10.1002","volume":"2024","author":[{"given":"Tin Zar","family":"Win","sequence":"additional","affiliation":[{"name":"School of Tropical Medicine and Global Health; Nagasaki University; Nagasaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Myat","family":"Han","sequence":"additional","affiliation":[{"name":"School of Tropical Medicine and Global Health; Nagasaki University; Nagasaki Japan"},{"name":"Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tansy","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health; London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu Thinzar","family":"Maung","sequence":"additional","affiliation":[{"name":"School of Tropical Medicine and Global Health; Nagasaki University; Nagasaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Brett-Major","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Biometrics; Uniformed Services University; Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Smith","sequence":"additional","affiliation":[{"name":"School of Tropical Medicine and Global Health; Nagasaki University; Nagasaki Japan"},{"name":"Department of Clinical Research, Faculty of Infectious and Tropical Diseases; London School of Hygiene & Tropical Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine; London UK"},{"name":"School of Tropical Medicine and Global Health, Nagasaki University; Nagasaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD014960.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1590\/S0036-46652003000300005","article-title":"Penicillin at the late stage of leptospirosis: a randomized controlled trial","volume":"45","author":"Costa","year":"2003","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"issue":"6","key":"10.1002\/14651858.CD014960.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1590\/S0036-46652000000600005","article-title":"Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure","volume":"42","author":"Daher","year":"2000","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"issue":"4","key":"10.1002\/14651858.CD014960.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.1988.39.388","article-title":"Penicillin therapy in icteric leptospirosis","volume":"39","author":"Edwards","year":"1988","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"6906","key":"10.1002\/14651858.CD014960.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(56)91853-0","article-title":"Chloramphenicol and penicillin in the treatment of leptospirosis among British troops in Malaya","volume":"270","author":"Fairburn","year":"1956","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-100-5-696","article-title":"Doxcycyline therapy for leptospirosis","volume":"100","author":"McClain","year":"1984","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/375226","article-title":"Ceftriaxone compared with sodium penicillin for treatment of severe leptospirosis","volume":"36","author":"Panaphut","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD014960.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/AAC.00508-07","article-title":"Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus","volume":"51","author":"Phimda","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/425001","article-title":"An open, randomized controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis","volume":"39","author":"Suputtamongkol","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"8583","key":"10.1002\/14651858.CD014960.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/s0140-6736(88)91230-5","article-title":"Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis","volume":"1","author":"Watt","year":"1988","journal-title":"Lancet"},{"issue":"7075","key":"10.1002\/14651858.CD014960.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(58)92405-X","article-title":"Treatment of leptospirosis with oxytetracycline","volume":"2","author":"Russell","year":"1958","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD014960.pub2-BIB0011|cit11","first-page":"313","article-title":"The enigma of the pathogenesis of the Jarisch-Herxheimer reaction","volume":"52","author":"Aronson","year":"1976","journal-title":"British Journal of Venereal Diseases"},{"issue":"2","key":"10.1002\/14651858.CD014960.pub2-BIB0012|cit12","first-page":"199","article-title":"Chemoprophylaxis with doxycycline in suspected epidemic of leptospirosis during floods: does this really work?","volume":"10","author":"Bhardwaj","year":"2010","journal-title":"African Health Sciences"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: a zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0014|cit14","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hrobjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive \u2013 trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0017|cit17","first-page":"199","article-title":"Leptospirosis diagnosis: competency of various laboratory tests","volume":"8","author":"Budihal","year":"2014","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4269\/ajtmh.16-0434","article-title":"The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis","volume":"96","author":"Butler","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"110","key":"10.1002\/14651858.CD014960.pub2-BIB0019|cit19","first-page":"1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0020|cit20","first-page":"501","article-title":"Antibiotics for the treatment of leptospirosis: systematic review and meta-analysis of controlled trials","volume":"4","author":"Charan","year":"2013","journal-title":"International Journal of Preventive Medicine"},{"issue":"9","key":"10.1002\/14651858.CD014960.pub2-BIB0021|cit21","first-page":"9","article-title":"Global morbidity and mortality of leptospirosis: a systematic review","volume":"17","author":"Costa","year":"2015","journal-title":"PLOS Neglected Tropical Disease"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0022|cit22","unstructured":"Covidence systematic review software Veritas Health Innovation"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0023|cit23","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0025|cit25","first-page":"251","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Doi","year":"2019"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0026|cit26","unstructured":"Eldridge S Campbell MK Campbell MJ Drahota AK Giraudeau B Reeves BC Revised Cochrane risk of bias tool for randomized trials (RoB 2). Additional considerations for cluster-randomized trials (RoB 2 CRT), 2020 sites.google.com\/site\/riskofbiastool\/welcome\/rob-2-0-tool\/rob-2-for-cluster-randomized-trials?authuser=0"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/C2010-0-66223-7","volume-title":"Manson's Tropical Diseases","author":"Farrar","year":"2014"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/bmj.325.7365.652","article-title":"Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis","volume":"325","author":"Fergusson","year":"2002","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0030|cit30","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0031|cit31","first-page":"65","article-title":"Leptospirosis in humans","volume":"387","author":"Haake","year":"2015","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0032|cit32","unstructured":"Higgins JP Sterne JA Savovi\u0107 J Page MJ Hr\u00f3bjartsson A Boutron I A revised tool for assessing risk of bias in randomized trials www.cochranelibrary.com\/documents\/20182\/64256496\/Cochrane+Methods+2016\/9cd61dd1-04c1-338c-2279-7aa30953451f 10.1002\/14651858.CD201601"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0033|cit33","unstructured":"Higgins JP Li T Sterne J Revised Cochrane 'Risk of bias' tool for randomized trials (RoB 2). Additional considerations for cross-over trials, 2020 drive.google.com\/file\/d\/18Ek-uW8HYQsUja8Lakp1yOhoFk0EMfPO\/view"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0034|cit34","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0035|cit35","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0036|cit36","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0037|cit37","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0038|cit38","first-page":"426","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Hooper","year":"2019"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0039|cit39","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2), 2016 database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"issue":"7","key":"10.1002\/14651858.CD014960.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2519\/jospt.2011.3333","article-title":"A guide to understanding meta-analysis","volume":"41","author":"Israel","year":"2011","journal-title":"Journal of Orthopaedic and Sports Physical Therapy"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10096-019-03797-4","article-title":"Leptospirosis: a neglected tropical zoonotic infection of public health importance \u2013 an updated review","volume":"39","author":"Karpagam","year":"2020","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0043|cit43","first-page":"277","volume-title":"Methods in Molecular Biology","volume":"2134","author":"Koizumi","year":"2020"},{"issue":"16","key":"10.1002\/14651858.CD014960.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1056\/NEJMp068050","article-title":"The NIH budget and the future of biomedical research","volume":"354","author":"Lagakos","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0045|cit45","unstructured":"Lasserson T Churchill R Chandler J Tovey D Higgins JP Standards for the reporting of protocols for new Cochrane Intervention Reviews. In: Higgins JP, Lasserson T, Chandler J, Tovey D, Churchill R. Methodological Expectations of Cochrane Intervention Reviews community.cochrane.org\/sites\/default\/files\/uploads\/MECIR%20Version%20February%202022.pdf"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0046|cit46","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0047|cit47","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"2","key":"10.1002\/14651858.CD014960.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.14.2.296-326.2001","article-title":"Leptospirosis","volume":"14","author":"Levett","year":"2001","journal-title":"Clinical Microbiology Reviews"},{"issue":"7300","key":"10.1002\/14651858.CD014960.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","article-title":"Forest plots: trying to see the wood and the trees","volume":"322","author":"Lewis","year":"2001","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD014960.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/eb-2014-101900","article-title":"Addressing missing outcome data in meta-analysis","volume":"17","author":"Mavridis","year":"2014","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0051|cit51","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Thomas J Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0052|cit52","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0053|cit53","first-page":"318","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Moffa","year":"2019"},{"issue":"8","key":"10.1002\/14651858.CD014960.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2010.03.004","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Moher","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1007\/s00586-005-1046-8","article-title":"Health related quality of life outcome instruments","volume":"15","author":"Nemeth","year":"2006","journal-title":"European Spine Journal"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0056|cit56","first-page":"359","volume-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","author":"Nesbitt","year":"2019"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0057|cit57","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0058|cit58","first-page":"n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0059|cit59","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12955-020-01347-7","article-title":"Quality of life assessment instruments for adults: a systematic review of population-based studies","volume":"18","author":"Pequeno","year":"2020","journal-title":"Health and Quality Life Outcomes"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/pathogens10091125","article-title":"Current evidence on the antimicrobial treatment and chemoprophylaxis of human leptospirosis: a meta-analysis","volume":"10","author":"Perez","year":"2021","journal-title":"Pathogen"},{"issue":"8","key":"10.1002\/14651858.CD014960.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.00044-08","article-title":"Antimicrobial susceptibilities of geographically diverse clinical human isolates of leptospira","volume":"52","author":"Ressner","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0064|cit64","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2023"},{"issue":"12","key":"10.1002\/14651858.CD014960.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/trstmh\/tru148","article-title":"High dose corticosteroids in severe leptospirosis: a systematic review","volume":"108","author":"Rodrigo","year":"2014","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0066|cit66","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013 Available from gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0067|cit67","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0068|cit68","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0069|cit69","first-page":"107","article-title":"Glucocorticoids in leptospira alveolar hemorrhage","volume":"81","author":"Soler","year":"2021","journal-title":"Medicina"},{"issue":"3","key":"10.1002\/14651858.CD014960.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0071|cit71","first-page":"e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"I4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD014960.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents \u2013 assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD014960.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.2011.11-0276","article-title":"Leptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease","volume":"85","author":"Suneth","year":"2011","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0075|cit75","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0076|cit76","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 Available from ctu.dk\/tsa\/learn-more"},{"issue":"10","key":"10.1002\/14651858.CD014960.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"e0004122","DOI":"10.1371\/journal.pntd.0004122","article-title":"Global burden of leptospirosis: estimated in terms of disability adjusted life years","volume":"9","author":"Torgerson","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/microbiolspec.ARBA-0029-2017","article-title":"Antimicrobial resistance in leptospira, brucella, and other rarely investigated veterinary and zoonotic pathogens","volume":"6","author":"Trott","year":"2018","journal-title":"Microbiology Spectrum"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0079|cit79","unstructured":"TSA \u2013 Trial Sequential Analysis Copenhagen Trial Unit 2021"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/B978-0-323-55512-8.00079-X","volume-title":"Hunter's Tropical Medicine and Emerging Infectious Diseases","author":"Vinetz","year":"2020"},{"issue":"21","key":"10.1002\/14651858.CD014960.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine \u2013 reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0082|cit82","first-page":"209","article-title":"On a strange, acute infectious disease, accompanied by swelling of the spleen, icterus, and nephritis","volume":"39","author":"Weil","year":"1886","journal-title":"Deutsches Archiv f\u00fcr klinische Medizin"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD014960.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"5","key":"10.1002\/14651858.CD014960.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1590\/S0036-46652003000500015","article-title":"Human leptospirosis: guidance for diagnosis, surveillance and control","volume":"45","author":"World Health Organization","year":"2003","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"key":"10.1002\/14651858.CD014960.pub2-BIB0087|cit87","unstructured":"World Health Organization Antibiotic resistance, 2020 www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance"},{"issue":"2","key":"10.1002\/14651858.CD014960.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008264.pub2","article-title":"Antibiotics for leptospirosis","author":"Brett-Major","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD014960.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001306","article-title":"Antibiotics for leptospirosis","author":"Guidugli","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD014960.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014960","article-title":"Antibiotics for treatment of leptospirosis","author":"Mukadi","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:20:03Z","timestamp":1756293603000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014960.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014960.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}